Wendi Rodigueza, Chief Scientific Officer at ProNAi Therapeutics Inc (DNAI), sold 4,000 shares at $9.59 ($40K) on 2016-01-20, disclosed to the SEC on 2016-01-22.
Open-market sale of $40k DNAI by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.59 | 1,000 | $10K | 24.0% |
| 2 | $10.32 | 1,000 | $10K | 25.9% |
| 3 | $10.32 | 1,000 | $10K | 25.9% |
| 4 | $9.66 | 1,000 | $10K | 24.2% |
| Total | $9.97 avg | 4,000 | $40K | 100% |